Visionary Holdings Inc. GV 深 滬
等待開盤 03-26 09:30:00 美东时间
0.235
-0.015
-6.00%
華盛通- 最 高0.4198
- 今 開0.20
- 成交量 3551.81万股
- 最 低 0.19
- 昨 收 0.25
- 總市值 131.77万
- 52周最高 4.18
- 市盈率 靜 --
- 換手率 633.42%
- 52周最低 0.19
- 委 比 93.55%
- 總股本 560.73万
- 歷史最高 420.00
- 量 比 9.08
- 振 幅 91.92%
- 歷史最低 0.19
- 每 手 1
- 風險率 0.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多11 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Gainers EpicQuest Education Group (NASDAQ:EEIQ) shares rose 12.1% to $2.5 duri...
03-25 20:05
Visionary Holdings (NASDAQ: GV) Provides 2026–2027 Growth Outlook; RAMU Anti-Aging Product Line Targets Potential $30 Million Annual Sales
Visionary Holdings Inc. outlines plans to expand into North America and Europe, focusing on medical aesthetics and healthcare services. The company expects its RAMU anti-aging product line to drive growth, with potential annual sales of $30 million. Key priorities include international market expansion, product commercialization, and developing integrated healthcare platforms. CEO Xiyong Hou emphasizes the importance of this phase for global grow...
03-05 14:30
10 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Gainers Classover Holdings (NASDAQ:KIDZ) shares moved upwards by 64.2% to $0.1...
03-04 20:05
Visionary Holdings Reports Continued Progress on US$9 Million Sales Contract
Visionary Holdings Reports Continued Progress on US$9 Million Sales Contract Visionary Holdings Inc. said its wholly owned subsidiary, Visionary Health Technology Group Limited (GV Hong Kong), is continuing execution of a previously signed commercial sales agreement valued at approximately US$9 mill
02-24 22:50
Visionary Holdings' Visionary Health Technology Forms Three New Regional Subsidiaries In China
Visionary Holdings Inc. ("GV" or the "Company") (Nasdaq: GV), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited, has established
02-18 22:33
Visionary Holdings (Nasdaq: GV) Establishes Three Wholly Owned Subsidiaries in Qingdao, Wuxi and Wuhu, Advancing Commercial Expansion in China
Visionary Holdings Inc. ("GV") has established three new wholly owned subsidiaries in Qingdao, Wuxi, and Wuhu, China, to expand its market presence, strengthen institutional partnerships, and enhance sales execution for its regenerative medicine and aesthetic treatment products. These subsidiaries are part of GV's multi-city commercialization strategy, aiming to improve scalability, institutional penetration, and revenue visibility across key reg...
02-18 14:31
Visionary Holdings Inc. Regains Compliance with Nasdaq Periodic Filing Requirement
Visionary Holdings Inc. has regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its delayed Annual Report on Form 20-F for the fiscal year ended March 31, 2025. Nasdaq confirmed the compliance on January 29, 2026, closing the related matter. The company remains committed to maintaining full compliance with Nasdaq listing standards and U.S. securities laws.
02-02 14:30
CORRECTION – Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending
Visionary Holdings Inc. 公布了截至2025年3月31日的最终年度报告和审计财务报表，尽管仍未向美国证交会提交Form 20-F。公司正从传统教育和房地产转型至健康管理、抗衰老及高端医美领域。2025财年总收入504万美元，同比下滑46.2%，新兴健康业务占总收入21.1%。净亏损1575万美元，主要源于转型投资和资产减值。毛利率增至28%，运营现金流为297万美元。未来，公司将深化健康管理和医美商业化，优化AI教育，并加强企业治理。
01-21 02:37
CORRECTION – Visionary Holdings Inc.
Visionary Holdings Inc. released its final FY2025 annual report and audited financial statements, showing total revenue of USD5.04 million, a 46.2% YoY decrease, with emerging health-related businesses contributing USD1.06 million (21.1% of total revenue). The company reported a net loss of USD15.75 million, primarily due to transformation investments and asset impairment charges. Gross margin improved to 28.0%, and cash flow from investing activ...
01-14 03:36
Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report
Visionary Holdings Inc. reported its fiscal year 2025 results, highlighting strategic transformation from traditional education and real estate to a diversified platform focused on health management, anti-aging, and premium medical aesthetics, alongside AI education. Revenue totaled USD 5.04 million, a 46.2% year-over-year decrease, with emerging health businesses contributing USD 1.06 million (21.1% of total revenue). The company incurred a net ...
01-13 04:38
